Table 3.
- | Pulmonary Arterial Systolic Pressure (PASP) | - | - | ||
---|---|---|---|---|---|
Parameter | Normal | Pulmonary Hypertension | Total | P-value | |
Gender | Female | 11 (73.3%) | 4 (26.7%) | 15 (100%) | 0.779 |
Male | 11 (68.8%) | 5 (31.2%) | 16 (100%) | ||
Total | 22 (71.0%) | 9 (29.0%) | 31 (100%) | ||
Use of hydroxyurea | Not used | 12 (63.2%) | 7 (36.8%) | 19 (100%) | 0.628 |
≤ 6 months | 3 (75.0%) | 1 (25.0%) | 4 (100%) | ||
≥ 6 months | 7 (87.5%) | 1 (12.5%) | 8 (100%) | ||
Total | 22 (71.0%) | 9 (29.0%) | 31 (100%) | ||
Smoking | None | 16 (88.9%) | 2 (11.1%) | 18 (100%) | 0.042 |
Passive | 4 (57.1%) | 3 (42.9%) | 7 (100%) | ||
Active | 2 (33.3%) | 4 (66.7%) | 6 (100%) | ||
Total | 22 (71.0%) | 9 (29.0%) | 31 (100%) |